Winn AN - Search Results

1

More evidence on the limited impact of state oral oncology parity laws.

Winn AN, Dusetzina SB. Winn AN, et al. Cancer. 2019 Feb 1;125(3):335-336. doi: 10.1002/cncr.31904. Epub 2018 Dec 19. Cancer. 2019. PMID: 30566761 Free PMC article.

2

Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia.

Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL. Dusetzina SB, et al. Among authors: winn an. J Clin Oncol. 2014 Feb 1;32(4):306-11. doi: 10.1200/JCO.2013.52.9123. Epub 2013 Dec 23. J Clin Oncol. 2014. PMID: 24366936

3

How Do Payers Respond to Regulatory Actions? The Case of Bevacizumab.

Dusetzina SB, Ellis S, Freedman RA, Conti RM, Winn AN, Chambers JD, Alexander GC, Huskamp HA, Keating NL. Dusetzina SB, et al. Among authors: winn an. J Oncol Pract. 2015 Jul;11(4):313-8. doi: 10.1200/JOP.2015.004218. Epub 2015 Jun 9. J Oncol Pract. 2015. PMID: 26060224 Free PMC article.

4

The association between trajectories of endocrine therapy adherence and mortality among women with breast cancer.

Winn AN, Dusetzina SB. Winn AN, et al. Pharmacoepidemiol Drug Saf. 2016 Aug;25(8):953-9. doi: 10.1002/pds.4012. Epub 2016 Apr 29. Pharmacoepidemiol Drug Saf. 2016. PMID: 27125337

5

Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia.

Winn AN, Keating NL, Dusetzina SB. Winn AN, et al. J Clin Oncol. 2016 Dec 20;34(36):4323-4328. doi: 10.1200/JCO.2016.67.4184. Epub 2016 Oct 31. J Clin Oncol. 2016. PMID: 27998234 Free PMC article.

6

Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis.

Chou YT, Winn AN, Rosenstein DL, Dusetzina SB. Chou YT, et al. Among authors: winn an. Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):676-684. doi: 10.1002/pds.4198. Epub 2017 Mar 19. Pharmacoepidemiol Drug Saf. 2017. PMID: 28317314 Free PMC article.

7

Reply to E. Ritchie et al.

Winn AN, Keating NL, Dusetzina SB. Winn AN, et al. J Clin Oncol. 2017 May 20;35(15):1745-1746. doi: 10.1200/JCO.2016.72.0037. Epub 2017 Feb 13. J Clin Oncol. 2017. PMID: 28524775 No abstract available.

8

Endocrine Therapy Initiation among Older Women with Ductal Carcinoma In Situ.

Anderson C, Winn AN, Dusetzina SB, Nichols HB. Anderson C, et al. Among authors: winn an. J Cancer Epidemiol. 2017;2017:6091709. doi: 10.1155/2017/6091709. Epub 2017 Sep 13. J Cancer Epidemiol. 2017. PMID: 29056966 Free PMC article.

9

Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws.

Dusetzina SB, Huskamp HA, Winn AN, Basch E, Keating NL. Dusetzina SB, et al. Among authors: winn an. JAMA Oncol. 2018 Jun 14;4(6):e173598. doi: 10.1001/jamaoncol.2017.3598. Epub 2018 Jun 14. JAMA Oncol. 2018. PMID: 29121177 Free PMC article.

10

Spending by Commercial Insurers on Chemotherapy Based on Site of Care, 2004-2014.

Winn AN, Keating NL, Trogdon JG, Basch EM, Dusetzina SB. Winn AN, et al. JAMA Oncol. 2018 Apr 1;4(4):580-581. doi: 10.1001/jamaoncol.2017.5544. JAMA Oncol. 2018. PMID: 29470578 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page